C. Ritacco, M. C. Köse, J. Courtois, L. Canti, C. Beguin, S. DUBOIS, B. Vandenhove et al. "Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells." iScience, 26, no. 3 (17 March 2023): 106085. doi:10.1016/j.isci.2023.106085 * These authors have contributed equally to this work. |
L. Canti, K. K. Ariën, I. Desombere, S. Humblet-Baron, P. Pannus, L. Heyndrickx, A. HENRY et al. "Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients." Cancer Cell, 40, no. 4 (11 April 2022): 335-337. doi:10.1016/j.ccell.2022.02.005 |
L. Canti* , S. Humblet-Baron* , I. Desombere, J. Neumann, P. Pannus, L. Heyndrickx, A. Henry et al. "Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients." Journal of hematology & oncology, 14, no. 1 (2021): 174. doi:10.1186/s13045-021-01190-3 * These authors have contributed equally to this work. |
J. Courtois, C. Ritacco, S. DUBOIS, L. Canti, B. Vandenhove, L. SEIDEL, C. Daulne et al. "Itacitinib prevents xenogeneic GVHD in humanized mice." Bone Marrow Transplantation, 56 (2021): 2672-2681. doi:10.1038/s41409-021-01363-1 |
G. Ehx* , C. Ritacco* , M. HANNON, S. DUBOIS, L. Delens, E. WILLEMS, S. SERVAIS, P. Drion, Y. BEGUIN, and F. Baron. "Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis." American Journal of Transplantation, 21 (2021): 2662-2674. doi:10.1111/ajt.16505 * These authors have contributed equally to this work. |
C. Ritacco* , G. Ehx* , C. GREGOIRE, C. Daulne, E. WILLEMS, S. SERVAIS, Y. BEGUIN, and F. Baron. "High proportion of terminally-differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation." Bone Marrow Transplantation, 56 (2021): 1828-1841. doi:10.1038/s41409-021-01221-0 * These authors have contributed equally to this work. |
A. Bolomsky, M. Vogler, M. C. Köse, C. A. Heckman, G. Ehx, H. Ludwig, and J. Caers. "MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents." Journal of hematology & oncology, 13, no. 1 (2020): 173. doi:10.1186/s13045-020-01007-9 |
L. Delens, G. Ehx, J. SOMJA, L. Vrancken, L. Belle, L. SEIDEL, C. Grégoire et al. "In Vitro Th17-Polarized Human CD4(+) T Cells Exacerbate Xenogeneic Graft-versus-Host Disease." Biology of Blood and Marrow Transplantation, 25 (2019): 204-215. doi:10.1016/j.bbmt.2018.10.007 |
C. Grégoire, C. Ritacco, M. Hannon, L. SEIDEL, L. Delens, L. Belle, S. DUBOIS et al. "Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model." Frontiers in Immunology, 10 (2019): 619. doi:10.3389/fimmu.2019.00619 |
G. Ehx, J. SOMJA, H.-J. Warnatz, C. Ritacco, M. HANNON, L. Delens, G. Fransolet et al. "Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2/HHD mice." Frontiers in Immunology, 9 (2018): 1943. doi:10.3389/fimmu.2018.01943 |
G. Ehx, G. Fransolet, L. De Leval, S. D'Hondt, S. Lucas, M. Hannon, L. Delens et al. "Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects." Oncoimmunology (2017): 6:e1314425. doi:10.1080/2162402X.2017.1314425 |
L. Belle* , G. Fransolet* , J. Somja, M. BINSFELD, P. Delvenne, P. Drion, M. Hannon, Y. BEGUIN, G. Ehx* , and F. Baron*. "Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease." PLoS ONE, 11 (12 December 2016): 0167997. doi:10.1371/journal.pone.0167997 * These authors have contributed equally to this work. |
G. Fransolet* , G. Ehx* , J. SOMJA, L. Delens, M. Hannon, J. Muller, S. DUBOIS et al. "Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease." Journal of Hematology and Oncology, 9 (04 July 2016): 53. doi:10.1186/s13045-016-0281-2 * These authors have contributed equally to this work. |
S. SERVAIS, Y. BEGUIN, L. Delens, G. Ehx, G. Fransolet, M. Hannon, E. WILLEMS, S. Humblet-Baron, L. Belle, and F. Baron. "Novel approaches for preventing acute graftversus- host disease after allogeneic hematopoietic stem cell transplantation." Expert Opinion on Investigational Drugs, 9 (11 May 2016): 957-972. doi:10.1080/13543784.2016.1182498 |
S. Göktuna, K. Shostak, T.-L. Chau, L. Heukamp, B. Hennuy, H. Q. Duong, A. LADANG et al. "The Prosurvival IKK-Related Kinase IKK« Integrates LPS and IL17A Signaling Cascades to Promote Wnt-Dependent Tumor Development in the Intestine." Cancer Research, 76 (2016): 2587-99. doi:10.1158/0008-5472.CAN-15-1473 |
M. HANNON, Y. BEGUIN, G. Ehx, S. SERVAIS, L. SEIDEL, C. Graux, J. Maertens et al. "Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation following Flu-TBI versus TLI-ATG Conditioning." Clinical Cancer Research, 21, no. 14 (15 July 2015): 3131-9. doi:10.1158/1078-0432.CCR-14-3374 |
G. Ehx* , M. Hannon* , Y. BEGUIN, S. Humblet-Baron* , and F. BARON*. "Validation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets." Oncotarget, 6 (2015): 43255-43266. doi:10.18632/oncotarget.6486 * These authors have contributed equally to this work. |
G. Ehx* , S. Gerin* , G. Mathy, F. Franck, H. C. Oliveira, A. E. Vercesi, and F. Sluse. "Liver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levels." Lipids in Health and Disease, 13 (21 July 2014): 116. doi:10.1186/1476-511X-13-116 * These authors have contributed equally to this work. |
F. Baron, S. Humblet-Baron, G. Ehx, S. SERVAIS, M. HANNON, L. Belle, C. LECHANTEUR et al. "Thinking out of the box - New approaches to controlling GVHD." Current Hematologic Malignancy Reports, 9 (2014): 73-84. doi:10.1007/s11899-013-0187-9 |
M. V. Ruiz, A. Apavaloaei, Q. Zhao, M.-P. Hardy, S. Lemieux, C. Perreault, and G. Ehx. "BamQuery: A new proteogenomic tool to explore the immunopeptidome and validate tumor‐specific antigens." European Journal of Immunology, 51, S1 (August 2021): 60. doi:10.1002/eji.202170200 |
C. Beguin, O. Kwan, C. Ritacco, J.-C. Debray, E. Dejardin, S. Dubois, M. C. Köse et al. "TNF-α priming of human regulatory T cells does not increase their ability to prevent xenogeneic graft-versus-host disease." Paper presented at Congrès annuel de la Société Francophone de Greffe de Moelle et Thérapie Cellulaire, Lille, France, 17 November 2023. |
M. V. Ruiz Cuevas, M.-P. Hardy, J.-D. Larouche, A. Apavaloaei, E. Kina, K. Vincent, P. Gendron et al. "BamQuery: a proteogenomic tool for the genome-wide exploration of the immunopeptidome." Eprint/Working Paper, United States: Cold Spring Harbor Laboratory, 2022. https://orbi.uliege.be2268/298884. doi:10.1101/2022.10.07.510944 * These authors have contributed equally to this work. |